M. Kandi

No ORCID on file · 1 paper in corpus

rct 2022

Therapeutic Effect of Bromocriptine as a Dopamine Agonist on Endometrioma Size: A Double-Blind Randomized Controlled Trial

·doi:10.15296/ijwhr.2023.27

Objectives:This study aimed to assess the therapeutic effect of a dopamine agonist (bromocriptine) together with medroxyprogesterone for three months on ovarian endometrioma size. Materials and Methods: In this double-blind randomized clini…